A Chinese research team has developed an injectable “bone glue” designed to improve surgical treatment of comminuted fractures, in which bones break into multiple fragments. The material is a dual-biomimetic hydrogel composed of caffeic acid-grafted collagen, aminated laponite and tetra-PEG-SC. This formulation provides substantial flexibility and strength, tolerating up to 98% compression and 600% tensile deformation. It is intended to maintain adhesion in blood-rich surgical environments while stabilising irregular bone fragments.
In preclinical studies involving rabbit radius and porcine femur fractures, the hydrogel produced more than twice the biomechanical and radiological performance of commercial cyanoacrylate adhesives. Beyond mechanical fixation, it appeared to support bone regeneration by reducing oxidative stress and promoting M2 macrophage polarisation, an immune response associated with tissue repair.
Comminuted fractures are challenging to treat because numerous small fragments can be difficult to secure with conventional plates and screws, increasing the risks of delayed healing, non-union and mal-union. A bioactive adhesive could potentially simplify fixation, encourage bone growth and reduce recovery time or complications.
However, the technology remains experimental. It has only been evaluated in animal models and is not approved for human use. Additional studies are needed to establish its safety, durability, effectiveness and immune effects before regulatory assessment and clinical trials. If these findings translate to humans, the hydrogel could provide a valuable adjunct or alternative to conventional fixation for complex fractures.
Article timeline
Build this article’s timeline
Extract dated events, key actors, and open questions using the same timeline analysis available in Signal.
European Medical Group LTD, European Medical Journal, and Creative Commons
🤖 AI prefill
📰What
A Chinese research team has developed an injectable “bone glue” designed to improve surgical treatment of comminuted fractures, in which bones break into multiple fragments.
🤖 AI prefill
📅When
2025 and 2026
🤖 AI prefill
📍Where
China
🤖 AI prefill
💡Why
Centers on dual-biomimetic bone adhesive, osteoimmunomodulatory capabilities, and comminuted fractures
🤖 AI prefill
Login to answer and earn XP for each gap you fill.
Manipulation Score: LowHow much this article uses emotional framing vs. straight reporting
Loaded Language2225%
Absolutist815%
Threat/Panic325%
Us vs Them015%
Engagement Bait1820%
Manipulation score look right?
Factual Claims (10)
mediumscientific
A research team from China created an injectable dual-biomimetic bone adhesive for comminuted fractures.
mediumscientific
The adhesive is made from caffeic acid-grafted collagen, aminated laponite, and tetra-PEG-SC.
mediumscientific
The material withstands up to 98% compression and 600% tensile deformation.
mediumhealth
The adhesive can hold bone fragments in place in a blood-rich surgical field.
highhealth
In rabbit radius and porcine femur fracture tests, treated bones showed over double the biomechanical and radiological performance of bones fixed with commercial cyanoacrylate adhesives.
mediumscientific
The adhesive reduced oxidative stress and promoted M2 macrophage polarisation around fracture sites.
lowhealth
Comminuted fractures have many small fragments and elevated risks of non-union or mal-union.
lowhealth
Traditional metal plates and screws have limitations for small or irregular bone fragments.
lowlegal
The technology is preclinical and has not been approved for human use.
mediumlegal
Further animal studies and regulatory review are needed before clinical trials can begin.
Comments
Login to view and post comments.